Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Corrigendum to "Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation" [Int. Immunopharmacol. 8 (2008) 1854-1858].
Int Immunopharmacol. 2020 Apr;81:106193. doi: 10.1016/j.intimp.2020.106193. Epub 2020 Mar 3.
Int Immunopharmacol. 2020.
PMID: 32139322
No abstract available.
Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation.
Sun Q, Zheng Y, Liu Q, Cao X.
Sun Q, et al.
Int Immunopharmacol. 2008 Dec 20;8(13-14):1854-8. doi: 10.1016/j.intimp.2008.08.009. Epub 2008 Sep 21.
Int Immunopharmacol. 2008.
PMID: 18789402
However, the underlying mechanisms responsible for antitumor effects of rapamycin remain to be fully elucidated. Here we report that rapamycin can reverse TLR4-triggered resistance of colon cancer cells to oxaloplatin- or doxorubicin-induced …
However, the underlying mechanisms responsible for antitumor effects of rapamycin remain to be fully elucidated. Here we report that …
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.